A study on the pharmaceutical companies of DSE listed firms of Bangladesh for the period of 2018 to 2022
This internship report is submitted in partial fulfillment of the requirements for the degree of Bachelor of Business Administration, 2023.
Autor principal: | Sushme, Sumaiya Selim |
---|---|
Altres autors: | Haque, Mohammad Mujibul |
Format: | Internship report |
Idioma: | English |
Publicat: |
Brac University
2024
|
Matèries: | |
Accés en línia: | http://hdl.handle.net/10361/22882 |
Ítems similars
-
Disclosure and compliance of IAS 16 in DSE listed pharmaceuticals companies in Bangladesh
per: Al-Mumen, Sk. Abdullah
Publicat: (2018) -
Empirical evidence of CAPM model at pharmaceutical industry of DSE
per: Islam, Md. Tariqul
Publicat: (2024) -
Response of market price relative to fundamentals of stocks : a case based approach on pharmaceutical industry listed in DSE
per: Faruquee, Murtaza
Publicat: (2013) -
Empirical analysis of 5 DSE equity traded through IDLC Investments Ltd & portfolio management
per: Ismail, Mohammed
Publicat: (2017) -
In-plant training at Healthcare Pharmaceuticals Limited
per: Rashid, Nowrin, et al.
Publicat: (2021)